- Ovid Therapeutics Inc To Host Research & Development (R&D) Day TranscriptOct 02, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Ovid Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Ovid Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Ovid Therapeutics Inc and Takeda Pharmaceutical Co Ltd to Discuss Strategic Transaction Call TranscriptMar 03, 2021
- Ovid Therapeutics Inc. - Special Call TranscriptOct 22, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptAug 25, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJul 13, 2020
- Ovid Therapeutics Inc. - Special Call TranscriptJun 17, 2020
- Ovid Therapeutics Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call TranscriptSep 23, 2019
- Ovid Therapeutics Inc. - Special Call TranscriptJun 27, 2019
Ovid Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to our next session here with Ovid Therapeutics. I'm Eason Lee, one of the associates on the biotech research team here at Needham. And it's my pleasure to be hosting Meg Alexander, the Chief Corporate Affairs Officer for the company. We'll be giving a presentation, and I think we'll have some time for Q&A afterwards.
(Conference Instructions) And with that, Meg, let me turn it over to you.
Thank you, Eason. Good morning, everyone. As Eason mentioned, I'm the Chief Strategy and Chief Corporate Affairs Officer. I'm standing in for Jeremy Levin today, our CEO and Chairman, who had a conflict. I'm very excited to give you an update on Ovid as well as our focus on epilepsy.
I should start by saying that we are a publicly traded company, and this presentation will include forward-looking statements. But for those of you who are not familiar with the Ovid's story, I'm very excited to bring you up
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)